ArticleNorthern clinics of Istanbul2025
Overview of blood transfusion appropriateness with one-day point prevalence: Right decision? Right product? Right amount?
Article in Northern clinics of Istanbul, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveBlood and blood products are a scarce resource and thus, they should be used efficiently. Inappropriate use of blood leads not only to waste of valuable medical resource, but also increases the risks of blood transfusion and economic burden.
methodsThis study is a prospective, observational one-day single-center point prevalence study in which transfusion activities performed in our hospital. It was aimed to determine the prevalence of patients receiving blood products in hospitals, types of blood products, characteristics of recipients, distributions of blood group, appropriateness of blood transfusion and the cost of these products, using the one-day standardized prevalence method for the first time in our country.
resultsOne hundred seventy blood transfusions were performed in 102 patients. It was found that 64 (37.6%) of 170 blood products used according to the guidelines were non-evidence-based and inappropriate blood transfusions. It was established that the frequency of inappropriate use of blood products was significantly higher in surgical divisions (n=31 48.4%) compared to internal medicine divisions (n=20, 31.3%) (p<0.0001). The amount corresponding to 64 (37.6%) units transfused inappropriately according to the guidelines was found for one day. When we estimated the results of this study at the level of yearly use of blood products, we found that transfusion of approximately 28 000 units of blood products was being performed yearly in our hospital and a total of 8.435.006 TL/281.166 USD was being spent yearly considering 10 523 units were being transfused inappropriately.
conclusionThis study shows that the condition in our country is only the tip of the iceberg. Examination of the indications for use of blood products by transfusion committees in hospitals and generalizing use of national guidelines could be the primary applications to prevent inappropriate use of blood products.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.